Panacea Biotec Ltd
NSE:PANACEABIO

Watchlist Manager
Panacea Biotec Ltd Logo
Panacea Biotec Ltd
NSE:PANACEABIO
Watchlist
Price: 433.25 INR 0.97% Market Closed
Market Cap: 26.5B INR
Have any thoughts about
Panacea Biotec Ltd?
Write Note

Panacea Biotec Ltd
Long-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Panacea Biotec Ltd
Long-Term Debt Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
Panacea Biotec Ltd
NSE:PANACEABIO
Long-Term Debt
â‚ą215.7m
CAGR 3-Years
-69%
CAGR 5-Years
-49%
CAGR 10-Years
N/A
Bharat Immunologicals and Biologicals Corporation Ltd
BSE:524663
Long-Term Debt
â‚ą35m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Transgene Biotek Ltd
BSE:526139
Long-Term Debt
â‚ą49.6m
CAGR 3-Years
2%
CAGR 5-Years
4%
CAGR 10-Years
N/A
Z
Zenotech Laboratories Ltd
BSE:532039
Long-Term Debt
â‚ą0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Hester Biosciences Ltd
NSE:HESTERBIO
Long-Term Debt
â‚ą1.6B
CAGR 3-Years
22%
CAGR 5-Years
23%
CAGR 10-Years
N/A
Biocon Ltd
NSE:BIOCON
Long-Term Debt
â‚ą134.2B
CAGR 3-Years
62%
CAGR 5-Years
50%
CAGR 10-Years
33%
No Stocks Found

Panacea Biotec Ltd
Glance View

Market Cap
26.5B INR
Industry
Biotechnology

Panacea Biotec Ltd. is a biotechnology company, which is engaged in the business of research, development, manufacture, and marketing of vaccines and pharmaceutical formulations. The company is headquartered in New Delhi, Delhi. The Company’s research areas include new chemical entities (NCE), new biological entities (NBE) novel drug delivery system (NDDS) based pharmaceutical formulations, novel peptides and human monoclonal antibodies and vaccine development. The Company’s product portfolio includes pain management, diabetes & cardiovascular management, oncology, renal disease management, osteoporosis management, anti-tubercular, gastrointestinal care products and vaccines. The Company’s subsidiaries include Panacea Biotec Pharma Limited, Panacea Biotec (International) SA, PanEra Biotec Private Limited and Meyten Realtech Private Limited.

PANACEABIO Intrinsic Value
178.94 INR
Overvaluation 59%
Intrinsic Value
Price

See Also

What is Panacea Biotec Ltd's Long-Term Debt?
Long-Term Debt
215.7m INR

Based on the financial report for Sep 30, 2024, Panacea Biotec Ltd's Long-Term Debt amounts to 215.7m INR.

What is Panacea Biotec Ltd's Long-Term Debt growth rate?
Long-Term Debt CAGR 5Y
-49%

Over the last year, the Long-Term Debt growth was 5%. The average annual Long-Term Debt growth rates for Panacea Biotec Ltd have been -69% over the past three years , -49% over the past five years .

Back to Top